[1] GANESAN P,KULIK L M.Hepatocellular carcinoma:new developments[J].Clin Liver Dis,2023,27(1):85-102. [2] 杨阔,高茸,马亚中,等.补骨脂素药理作用及肝毒性机制的研究进展[J].中草药,2021,52(1):289-298. [3] LI L H,ZOU T T,LIANG M,et al.Screening of metabolite s in the treatment of liver cancer xenografts HepG2/ADR by psoralen-loaded lipid nanoparticles[J].Eur J Pharm Biopharm,2021,165:337-344. [4] WANG X H,XU C F,HUA Y T,et al.Psoralen induced cell cycle arrest by modulating Wnt/β-catenin pathway in breast cancer cells[J].Sci Rep,2018,8(1):14001. [5] FINOTELLO F,DI CAMILLO B.Measuring differential gene expression with RNA-seq:challenges and strategies for data analysis[J].Brief Funct Genomics,2015,14(2):130-142. [6] 周昆,王安红,柴丽娟,等.补骨脂酚对HepG2的细胞毒性及BSEP、NTCP、FXR、CYP7A1的影响[J].毒理学杂志,2015,29(3):193-196. [7] 崔凯,吴伟伟,刁其玉.转录组测序技术的研究和应用进展[J].生物技术通报,2019,35(7):1-9. [8] INGHAM M,SCHWARTZ G K.Cell-cycle therapeutics come of age[J].J Clin Oncol,2017,35(25):2949-2959. [9] KNUDSEN E S,KUMARASAMY V,NAMBIAR R,et al.CDK/cyclin dependencies define extreme cancer cell-cycle heterogeneity and collateral vulnerabilities[J].Cell Rep,2022,38(9):110448. [10] WU L Y,YIN L,MA L X,et al.Comprehensive bioinformatics analysis of ribonucleoside diphosphate reductase subunit M2(RRM2) gene correlates with prognosis and tumor immunotherapy in pan-cancer[J].Aging,2022,14(19):7890-7905. [11] KNUDSEN E S,KUMARASAMY V,NAMBIAR R,et al.CDK/cyclin dependencies define extreme cancer cell-cycle heterogeneity and collateral vulnerabilities[J].Cell Rep,2022,38(9):110448. [12] CHEN J D.The cell-cycle arrest and apoptotic functions of p53 in tumor initiation and progression[J].Cold Spring Harb Perspect Med,2016,6(3):a026104. [13] WANG Z X.Regulation of cell cycle progression by growth factor-induced cell signaling[J].Cells,2021,10(12):3327. [14] JIN C Y,DU L,NUERLAN A H,et al.High expression of RRM2 as an independent predictive factor of poor prognosis in patients with lung adenocarcinoma[J].Aging,2020,13(3):3518-3535. [15] YANG P M,LIN L S,LIU T P.Sorafenib inhibits ribonucleotide reductase regulatory subunit M2 (RRM2) in hepatocellular carcinoma cells[J].Biomolecules,2020,10(1):117. [16] SEEWOO V,YANG W P,DU H L,et al.The different induction mechanisms of growth arrest DNA damage inducible gene 45 β in human hepatoma cell lines[J].Chemotherapy,2012,58(2):165-174. [17] QIU W H,DAVID D,ZHOU B S,et al.Down-regulation of growth arrest DNA damage-inducible gene 45beta expression is associated with human hepatocellular carcinoma[J].Am J Pathol,2003,162(6):1961-1974. |